Showing results (141-150 of 244) with videos related to

Sort By:
Pageof 25
Advances in Radiation Oncology|March 18, 2024
Tolerance of Concurrent Adjuvant Radiation Therapy and Pembrolizumab for Triple Negative Breast Cancer: Real Life ExperienceThais Tison, Pierre Loap, Emilie Arnaud, et al.
Breast Cancer Research : BCR|March 7, 2021
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patientsLauren Darrigues, Jean-Yves Pierga, Alice Bernard-Tessier, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2017
RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric studyChristophe Massard, Isabelle Borget, Françoise Farace, et al.
Clinical Chemistry|January 12, 2017
Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast CancerFrancesca Riva, Francois-Clement Bidard, Alexandre Houy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2019
Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 TrialAnne-Sophie Hamy, Sandrine Tury, Xiaofei Wang, et al.
Plos One|June 10, 2011
The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinomaFabien Reyal, Roman Rouzier, Berenice Depont-Hazelzet, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2009
Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinomaAnne Vincent-Salomon, Martial Caly, Yann De Rycke, et al.
Pageof 25